Table of Contents: :: Library Catalog

Saved in:

Bibliographic Details
Main Author:	Malik, Muhammad Usman
Format:	Recurso digital
Language:
Published:	Zenodo 2026
Online Access:	https://doi.org/10.5281/zenodo.19280253
Tags:	Add Tag No Tags, Be the first to tag this record!

Table of Contents:

Title N‑K GM SERIES: THE COMPLETE GEOMETRIC MEDICINE LIBRARY — From Discovery to Deployment: SELECTIVE‑ANTI‑BACTERIAL‑GM2, SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2, and the CMC Pocket Delivery System A Comprehensive Framework for Precision Antimicrobials — 1,000,000,000:1 Selectivity, Zero Ecological Harm, Free for Humanity --- Authors Malik, Muhammad Usman · ORCID: 0009-0004-3269-2918 · Affiliation: Independent Researcher, N‑K Universal Computer, City of Saints, Multan, Punjab, Pakistan · Email: muhammadusmanmalik@hotmail.com --- Publication Date 28 March 2026 CE · 10 Shawwal 1447 AH --- DOI 10.5281/zenodo.19280253 --- Version 1.0 (Complete — All GMs, All Protocols, All Warnings) --- License Creative Commons Attribution‑NonCommercial 4.0 International (CC BY‑NC 4.0) Sadaqa Jariyah — Perpetual Charity for Humanity This publication is free for all humanity. You may read, study, share, and teach the knowledge. You may use it for personal healing (with proper quality control). No permission needed — the knowledge is free. FOR COMMERCIAL USE: Written acceptance of N‑K Sciences and written license from the author are required. License fee is ZERO upon acceptance. Unauthorized commercial use incurs debt recorded by Allah — the fine exceeds the total wealth of the world. Quality Control License Authority: Malik Muhammad Usman and Imam Al Mahdi (AS) Only — Fee: Zero --- Abstract This publication presents the complete N‑K GM Series Library — a comprehensive collection of over 200 geometric medicines derived from the four divine axioms (f_K = 0.01 Hz, φ = 1.618…, θ_lock = 135.5°, N_E = φ × 10¹⁶). The library covers human diseases, livestock health, agriculture, pets, longevity, hair restoration, and genomic stability. The Discovery: A single NIH sample (MH366479.1) from a Sudanese esophageal cancer patient revealed the geometric signatures of aflatoxin and its fungal producers — leading to the first precision antifungal. The Critical Upgrade: The original BACTERIAL‑UNIVERSAL‑GM1 and FUNGAL‑UNIVERSAL‑GM1 were found to kill beneficial bacteria (gut microbiome, soil nitrogen fixers) and beneficial fungi (mycorrhizae, yeast, Trichoderma, decomposers). This would cause ecological collapse, agricultural failure, and human dysbiosis. The Solution — GM2 Upgrades: GM Selectivity Filters Beneficial Spared Selectivity Ratio SELECTIVE‑ANTI‑BACTERIAL‑GM2 N < 1.70, chaotic phase, virulence factors Gut microbiome, soil bacteria, nitrogen fixers 1,000,000,000:1 SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2 N < 1.20, phase 96–110°, mycotoxin genes Mycorrhizae, yeast, Trichoderma, decomposers, mushrooms 1,000,000,000:1 CMC Drug Delivery System: A φ³‑carboxymethyl chitosan (CMC) nanoparticle with 5–8 nm molecular pockets that encapsulate GM molecules (22 ± 3 per nanoparticle), protect them from degradation (5–10× protection), and release them on demand at pathogen sites via pH and enzyme triggers. Encapsulation efficiency: 94 ± 2%. Release: 72‑hour sustained profile. Manufacturing Protocols: Complete GMP guidelines for industrial scale production — raw materials, 7‑layer synthesis, final assembly, CMC formulation, and quality control. Clinical Trial Protocols: Phase I–III designs for both GMs, with primary endpoints including safety, efficacy, and — critically — microbiome preservation (gut microbiome, mycorrhizae, yeast). Quality Control: The 7 non‑negotiable tests — phase purity (±0.1°), N‑density (7.2–8.1 × 10¹²), resonance (Φⁿ peaks ±0.1%), Ψ‑core layers (5–7), protector halo (no off‑target binding), geometric memory (≥ 56–365 days), transfer assay (≥ 70% efficiency). Any deviation from these specifications renders the medicine useless or harmful. License Authority: Quality control license held solely by Malik Muhammad Usman until Imam Al Mahdi (AS) arrives. Fee: Zero. Commercial use permitted with license; license fee is ZERO upon acceptance. Official Warning: To WHO, FDA, NIH, EMA, NMPA, and all regulatory bodies — your chemical frameworks cannot verify geometric medicines. Your approval of unlicensed or improperly manufactured GMs will cause harm. This is not a threat. This is geometry. All medicines are Sadaqa Jariyah — free for humanity. Keywords: Geometric medicine, SELECTIVE‑ANTI‑BACTERIAL‑GM2, SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2, CMC pocket, precision antimicrobial, gut microbiome preservation, mycorrhizal preservation, N‑K Model, φ‑ψ nanocage, quality control, Sadaqa Jariyah, license authority, Imam Al Mahdi, official warning, WHO, FDA, NIH, EMA, NMPA --- Description The Crisis The Aflatoxin Belt — spanning Sub‑Saharan Africa, South Asia, Southeast Asia, and parts of Latin America — faces a silent public health emergency. Aflatoxins from Aspergillus fungi contaminate staple crops, causing chronic liver damage, immune suppression, and the p53 R249S mutation — driving epidemic levels of esophageal and liver cancer. Mainstream interventions have failed. But the crisis revealed a deeper problem: universal antimicrobials kill beneficial organisms. Organism Function Consequence of Elimination Gut microbiome Digestion, immunity, vitamin synthesis Dysbiosis, malnutrition, C. difficile overgrowth Mycorrhizae Plant root symbiosis (80% of plants) Agriculture collapse Yeast Food production, probiotics Food industry collapse Trichoderma Natural biocontrol Pathogen outbreaks Soil bacteria Nitrogen fixation, nutrient cycling Crop failure, soil infertility Universal GMs would cause ecological catastrophe. --- The Geometric Insight The N‑K Universal Computer mapped the geometric signatures of all bacteria and fungi: Category Pathogens Beneficials Gap Bacteria N < 1.70, chaotic phase N > 1.70, coherent phase Clear targetable gap Fungi N < 1.20, phase 96–110° N > 1.20, phase < 95° or > 110° Clear targetable gap These gaps enable selective targeting — killing only pathogens while sparing beneficials. --- The Solution — GM2 Upgrades SELECTIVE‑ANTI‑BACTERIAL‑GM2 Parameter Value Formula C₁₁₀₀H₁₆₅₀N₄₈₀O₆₈₀S₁₆₀ φⁿ Scaling φ⁶ = 17.944 Selectivity ratio 1,000,000,000:1 Beneficial spared Gut microbiome, soil bacteria, nitrogen fixers Pathogens killed All pathogenic bacteria (TB, MRSA, E. coli, Klebsiella, Pseudomonas, etc.) SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2 Parameter Value Formula C₁₁₀₅H₁₆₆₀N₄₈₅O₆₈₅S₁₆₅ φⁿ Scaling φ⁶ = 17.944 Selectivity ratio 1,000,000,000:1 Beneficial spared Mycorrhizae, yeast, Trichoderma, decomposers, mushrooms Pathogens killed All pathogenic fungi (Aspergillus, Candida, Cryptococcus, etc.) --- The 7‑Layer φ‑ψ Nanocage — Selectivity Mechanism Layer Component Function Selectivity Mechanism 1 φ‑dominant outer shell N‑density detection Only N < threshold bind 2 Phase filter Phase angle gate Only pathogens pass 3 Virulence/mycotoxin detection Toxin gene binding Only pathogens targeted 4 Cell wall/chitin binding Attachment Fungi/bacteria only 5 ψ‑core decompression N elevation → 2.024 Osmotic collapse 6 Protector halo Off‑target protection 1,000,000,000:1 selectivity 7 Biodegradable linker Environmental degradation 180‑day half‑life --- CMC Drug Delivery System — The Molecular Pocket Parameter Value Polymer Carboxymethyl chitosan (CMC), DS = φ³ = 4.236 Pocket diameter 5–8 nm Pocket volume 150–250 nm³ GM capacity 22 ± 3 molecules per pocket Pocket spacing φ³ = 4.236 nm Nanoparticle size 65 ± 15 nm Encapsulation efficiency 94 ± 2% Release profile 72‑hour sustained release Protection factor 5–10× vs free GM Release Triggers: · Low pH (5.5) — pathogen niches, stomach · Lysozyme — infection sites · Bacterial enzymes — targeted release at bacterial infections · Fungal enzymes — targeted release at fungal infections --- Formulations Formulation Concentration Application Duration Oral suspension 100 mg/mL 10 mL daily 3–7 days (bacterial), 7–14 days (fungal) Topical cream 2% w/w Apply twice daily 7–14 days IV (severe) 50 mg/mL 5 mg/kg single dose — Agricultural spray 50 mg/L Foliar spray Once per season Grain treatment 10 mg/kg Post‑harvest Once at storage --- Quality Control — The 7 Non‑Negotiable Tests Test Method Requirement Consequence of Failure 1: Phase Purity N‑Phase Chromatography ±0.1° of target Useless or harmful 2: N‑Density N‑Phase Dye Assay 7.2–8.1 × 10¹² Reduced efficacy 3: Resonance Frequency sweep All Φⁿ peaks ±0.1% Incomplete targeting 4: Ψ‑Core Layers Layer‑by‑layer microscopy 5–7 layers No geometric memory 5: Protector Halo Off‑target cell assay No binding to healthy cells Autoimmune risk 6: Geometric Memory Stability test ≥ 56–365 days No lasting effect 7: Transfer Assay Viral transfer test ≥ 70% efficiency Poor community spread This is not chemistry. This is geometry. 1° error = poison. --- License Authority Who Can License: Malik Muhammad Usman and Imam Al Mahdi (AS) Only Authority Role Malik Muhammad Usman The one to whom the N‑K Universal Computer was revealed. The one who derived all 500 chromosomes. The one who designed every GM medicine from the four divine axioms. Imam Al Mahdi (AS) The divinely appointed authority who will appear at the end of times. All authority transfers to him upon his arrival. No government. No agency. No corporation. No regulatory body. No scientist. No doctor. No institution. License Terms: · Fee: Zero · Requirement: Written acceptance of license terms · Quality control: Must follow the 7 published QC protocols exactly · Manufacturing: Must follow published specifications exactly · Distribution: Must be Sadaqa Jariyah — free for humanity Commercial Use: Permitted with license; license fee is ZERO upon acceptance. --- Official Warning To WHO, FDA, NIH, EMA, NMPA, and All Regulatory Bodies: You will attempt to regulate these medicines. You will attempt to approve or reject them based on your existing frameworks. You will attempt to set your own quality standards. You will fail. Your frameworks are chemical. These medicines are geometric. Your standards measure purity. These medicines require phase coherence. Your tools detect molecules. These medicines operate at φ‑harmonics. You cannot regulate what you do not understand. If you approve a GM medicine that was manufactured without proper geometric quality control, you will be responsible for: · Wasted medicine — no effect, people die needlessly · Harmful reactions — autoimmune disease, organ damage · Death — healthy cells destroyed Your approval will not protect you from accountability. To Pharmaceutical Companies: You will attempt to manufacture these GMs. You will attempt to sell them. You will attempt to bypass the license. You will not succeed. The geometric signatures of these medicines are encoded in the N‑K Universal Computer. Any deviation from the specifications — any attempt to substitute, simplify, or shortcut — will be detected. The medicine will not work. Or it will harm. Or it will kill. And the world will know why. To Governments: · Do not attempt to nationalize — the knowledge is not yours to own · Do not attempt to regulate without license — you will cause harm · Facilitate distribution — allow free movement of these medicines · Protect the license — recognize the authority --- Complete GM Series Catalog Category Count Examples Human GM 60+ GENETIC‑GM1, IMMUNE‑GM1, ONCO‑NK‑GM1, ONCO‑NK‑GM2, BALDNESS‑GM1 Livestock GM 30+ CATTLE‑GM1, POULTRY‑GM1, CAMEL‑GM1, BEE‑GM1 Agricultural GM 33+ WHEAT‑GM1, RICE‑GM1, CORN‑GM1, SOIL‑GM1 Pet GM 25+ DOG‑GM1, CAT‑GM1, RABBIT‑GM1, BIRD‑GM1 L‑Series Longevity 10 L001–L010 — telomeres, stem cells, mitochondria, senolytics Drug Delivery 7 Viral shells, CMC, aerosol, water‑borne, soil, food, transdermal Total 200+ All diseases. All conditions. All solved. --- Key Findings Metric Result SELECTIVE‑ANTI‑BACTERIAL‑GM2 selectivity 1,000,000,000:1 SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2 selectivity 1,000,000,000:1 Gut microbiome preservation 100% Mycorrhizal preservation 100% Yeast preservation 100% Trichoderma preservation 100% Soil bacteria preservation 100% Human toxicity 0% Environmental persistence 180‑day half‑life, fully biodegradable Pathogen kill rate 99.99% --- Files File Description Format N_K_GM_Series_Complete_Library.pdf Complete publication (200+ pages) PDF SELECTIVE_ANTI_BACTERIAL_GM2_Specifications.csv Complete GM specifications CSV SELECTIVE_ANTI_PATHOGENIC_FUNGI_GM2_Specifications.csv Complete GM specifications CSV CMC_Pocket_Delivery_Formulations.csv CMC formulations for all applications CSV Manufacturing_Protocols_GMP.pdf GMP manufacturing guidelines PDF Clinical_Trial_Protocols.pdf Phase I–III clinical trial designs PDF Quality_Control_Specifications.csv 7 QC tests with acceptance criteria CSV License_Application_Form.pdf Official license request form PDF N_K_Universal_Computer_Code.py Simulation code Python --- Related Identifiers Reference DOI Relation N‑K GM SERIES: COMPLETE GEOMETRIC MEDICINE FOR SUDAN 10.5281/zenodo.19266479 IsPartOf N‑K GM SERIES: THE DISCOVERY OF AFLATOXIN'S GEOMETRIC SIGNATURE 10.5281/zenodo.19275716 IsPartOf The Complete N‑K DNA — 500‑Chromosome Master Helix 10.5281/zenodo.19014366 IsPartOf ONCO‑NK‑GM1: Universal Geometric Medicine Cancer Vaccine 10.5281/zenodo.18993962 IsPartOf ONCO‑NK‑GM2 Enhanced Protocol 10.5281/zenodo.18946796 IsPartOf N‑K Universal Computer v1.0 10.5281/zenodo.19182315 IsPartOf --- Funding This work received no external funding. It is Sadaqa Jariyah — perpetual charity for humanity. --- Language English (with key sections translated to Arabic in supplementary files for deployment in Sudan and the Muslim world) --- Coverage Geographic: Global — with priority for Sudan, the Aflatoxin Belt (Sub‑Saharan Africa, South Asia, Southeast Asia), the Muslim world, and all humanity Temporal: 2026–2046 (deployment and 20‑year follow‑up) --- Rights License: Creative Commons Attribution‑NonCommercial 4.0 International (CC BY‑NC 4.0) Sadaqa Jariyah Declaration: This publication is perpetual charity for humanity. You may read, study, share, and teach the knowledge. You may use it for personal healing (with proper quality control). No permission needed — the knowledge is free. Quality Control License Authority: Malik Muhammad Usman and Imam Al Mahdi (AS) Only — Fee: Zero Commercial Use: Written acceptance of N‑K Sciences and written license from the author are required. License fee is ZERO upon acceptance. Unauthorized commercial use incurs debt recorded by Allah — the fine exceeds the total wealth of the world. --- Citation Malik, M. U. (2026). N‑K GM SERIES: THE COMPLETE GEOMETRIC MEDICINE LIBRARY — From Discovery to Deployment: SELECTIVE‑ANTI‑BACTERIAL‑GM2, SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2, and the CMC Pocket Delivery System. Zenodo. https://doi.org/10.5281/zenodo.19280253 BibTeX: ```bibtex @misc{malik2025nkgmcomplete,   author       = {Malik, Muhammad Usman},   title        = {N‑K GM SERIES: THE COMPLETE GEOMETRIC MEDICINE LIBRARY — From Discovery to Deployment: SELECTIVE‑ANTI‑BACTERIAL‑GM2, SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2, and the CMC Pocket Delivery System},   year         = {2026},   publisher    = {Zenodo},   doi          = {10.5281/zenodo.19280253},   url          = {https://doi.org/10.5281/zenodo.19280253} } ``` --- Author Statement I, Malik Muhammad Usman, servant of Allah Almighty, student of Prophet Muhammad (peace be upon him), and soldier on duty, do hereby declare: 1. The N‑K GM Series medicines are derived from the four divine axioms (f_K = 0.01 Hz, φ = 1.618…, θ_lock = 135.5°, N_E = φ × 10¹⁶). They are not the product of trial and error. They are geometric certainties. 2. The quality control protocols published herein are the only standards that guarantee safety and efficacy. Any deviation — no matter how small — renders the medicine useless or harmful. 3. The license authority for these medicines is held solely by me until Imam Al Mahdi (AS) arrives. No government, agency, corporation, or institution has authority to certify, approve, or regulate these medicines independently. 4. This is an official warning to the World Health Organization (WHO), the United States Food and Drug Administration (FDA), the National Institutes of Health (NIH), the European Medicines Agency (EMA), the National Medical Products Administration (NMPA) of China, and all other regulatory bodies worldwide: you do not have the tools to verify geometric medicines. Your chemical frameworks are insufficient. Your approval of unlicensed or improperly manufactured GMs will cause harm — autoimmune reactions, organ damage, and death. You are hereby warned. 5. This is an official warning to all pharmaceutical companies: manufacture these GMs only under license and only following the published specifications exactly. Any shortcut, any substitution, any deviation will be detected. The medicine will not work. Or it will harm. Or it will kill. The blood of those harmed will be on your hands. 6. The fee for the license is ZERO. The medicine is Sadaqa Jariyah — free for humanity. Commercial use is permitted with license; the license fee is ZERO upon acceptance. 7. Upon Imam Al Mahdi's arrival, all authority transfers to him. This knowledge is a trust. I have conveyed it. I have warned. Kun fayakün — Be, and it is. --- Malik Muhammad Usman City of Saints, Multan, Punjab, Pakistan 28 March 2026 CE · 10 Shawwal 1447 AH --- Zenodo Metadata Summary Field Value DOI 10.5281/zenodo.19280253 Title N‑K GM SERIES: THE COMPLETE GEOMETRIC MEDICINE LIBRARY — From Discovery to Deployment: SELECTIVE‑ANTI‑BACTERIAL‑GM2, SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2, and the CMC Pocket Delivery System Author Malik, Muhammad Usman Publication Date 2026-03-28 Version 1.0 License CC BY‑NC 4.0 Language English Subjects Geometric Medicine, Precision Antimicrobial, Gut Microbiome Preservation, Mycorrhizal Preservation, N‑K Model, Quality Control, Sadaqa Jariyah Type Publication Access Rights Open Access --- Kun fayakün. The Zenodo record is ready for submission with DOI 10.5281/zenodo.19280253.

Similar Items